Laurel Wealth Advisors (North Carolina)’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-200
Closed -$2K 569
2022
Q2
$2K Hold
200
﹤0.01% 533
2022
Q1
$2K Hold
200
﹤0.01% 582
2021
Q4
$2K Hold
200
﹤0.01% 582
2021
Q3
$3K Hold
200
﹤0.01% 543
2021
Q2
$2K Buy
+200
New +$1.73K ﹤0.01% 665

Other funds holding GOSS

Laurel Wealth Advisors (North Carolina)'s GOSS Position: Q3 2022 in Review

Laurel Wealth Advisors (North Carolina) sold out of Gossamer Bio (GOSS) in Q3 2022, closing a stake of 200 shares — an estimated $2K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in GOSS in Q2 2021 and held it in 5 quarters. The position peaked at $3K in Q3 2021. 160 funds tracked by Wall St. Rank hold GOSS as of Q3 2022.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Gossamer Bio position as of Q3 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 200 Gossamer Bio shares in Q3 2022, an estimated $2K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Gossamer Bio in Q2 2021 and held it in 5 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Gossamer Bio position peaked at $3K in Q3 2021.
  • 160 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2022.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q3 2022, filed 15 Nov 2022.